日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Once-daily oral ritlecitinib or brepocitinib versus placebo in patients with moderate-to-severely active Crohn's disease (PIZZICATO): an international, randomised, phase 2a trial

每日一次口服利特西替尼或布雷泊西替尼与安慰剂治疗中重度活动性克罗恩病患者的疗效比较(PIZZICATO):一项国际性、随机、2a期试验

Vermeire, Severine; Allegretti, Jessica R; Kim, Hyo Jong; Long, Millie D; Leszczyszyn, Jaroslaw; Schreiber, Stefan; Kierkus, Jaroslaw; Chandler, Paulette D; Ramakrishna, Jyoti; Peeva, Elena; Vincent, Michael S; Shojaee, Negin; Mahling, Ping; Banfield, Christopher; Banerjee, Anindita; Gale, Jeremy D; Hung, Kenneth E

Benefit-risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn's disease

乌帕替尼的获益风险比:对中重度活动性溃疡性结肠炎或克罗恩病患者的 2b/3 期研究进行探索性事后分析

Vermeire, Severine; Colombel, Jean-Frederic; Danese, Silvio; Panaccione, Remo; Peyrin-Biroulet, Laurent; Beck, Kendall; Chaparro, María; Gisbert, Javier P; Dubcenco, Elena; Klaff, Justin; Naling, Grace; Ford, Sharanya; Remple, Valencia; Joshi, Namita; Suravaram, Smitha; Duncan, Benjamin; Wang, Yibo; Wick-Urban, Bettina; Loftus, Edward V

Author Correction: A20 controls intestinal homeostasis through cell-specific activities

作者更正:A20 通过细胞特异性活动控制肠道稳态。

Vereecke, Lars; Vieira-Silva, Sara; Billiet, Thomas; van Es, Johan H; Mc Guire, Conor; Slowicka, Karolina; Sze, Mozes; van den Born, Maaike; De Hertogh, Gert; Clevers, Hans; Raes, Jeroen; Rutgeerts, Paul; Vermeire, Severine; Beyaert, Rudi; van Loo, Geert

Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patients

托法替尼对巨噬细胞活化的不同影响是导致溃疡性结肠炎患者疗效不佳的原因之一。

Melón-Ardanaz, Elisa; Veny, Marisol; Corraliza, Ana M; Gudiño, Victoria; Garrido-Trigo, Alba; Sanzo-Machuca, Ángela; Buendia, Marc; Esteller, Miriam; Robbins-Moreno, Lisseth; Rodrigo, Maite; Masamunt, M Carme; Giner, Ángel; Gallego, Marta; Ordás, Ingrid; Fernández-Clotet, Agnès; Caballol, Berta; Corbí, Ángel; Verstockt, Bram; Vermeire, Severine; Panés, Julian; Ricart, Elena; Salas, Azucena

Obefazimod in patients with moderate-to-severely active ulcerative colitis: efficacy and safety analysis from the 96-week open-label maintenance phase 2b study

奥贝法齐莫德治疗中重度活动性溃疡性结肠炎患者的疗效和安全性分析:一项为期 96 周的开放标签维持期 2b 研究

Vermeire, Severine; Nitcheu, Josianne; Gineste, Paul; Flatres, Aurélien; Santo, Julien; Scherrer, Didier; Peyrin-Biroulet, Laurent; Dulai, Parambir S; Danese, Silvio; Dubinsky, Marla; Tilg, Herbert; Siegmund, Britta; Hisamatsu, Tadakazu; Shan, Kejia; Rabbat, Christopher J; Sands, Bruce E

Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial

既往生物制剂暴露对奥扎尼莫德在3期True North临床试验中的疗效和安全性的影响

Sands, Bruce E; Rubin, David T; Loftus, Edward V Jr; Wolf, Douglas C; Panaccione, Remo; Colombel, Jean-Frederic; Dignass, Axel; Regueiro, Miguel; Vermeire, Severine; Afzali, Anita; Lawlor, Garrett; Ahmad, Harris A; Wu, Hsiuanlin; Osterman, Mark T; Jain, Anjali; D'Haens, Geert

Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study

Mirikizumab 可改善中重度活动性克罗恩病患者的生活质量和工作效率:VIVID-1 III 期研究结果

Lee, Scott D; Vermeire, Severine; Ungaro, Ryan; Vadhariya, Aisha; Durand, Frederick; Morris, Nathan; Yu, Guanglei; Fisher, Deborah A; Traxler, Kristina; Long, Millie

Environmental and Inflammatory Factors Drive Perinuclear-Antineutrophil Cytoplasmic Antibodies (pANCA) in Ulcerative Colitis: A European Twin Study

环境和炎症因素驱动溃疡性结肠炎患者核周抗中性粒细胞胞浆抗体 (pANCA) 的产生:一项欧洲双胞胎研究

Bergemalm, Daniel; Amcoff, Karin; Pierik, Marie J; Colombel, Jean-Frederic; Vermeire, Severine; Bodin, Lennart; Carlson, Marie; Halfvarson, Jonas

Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study

Mirikizumab 治疗溃疡性结肠炎 152 周连续治疗三年后的疗效和安全性:LUCENT-3 开放标签扩展研究的结果

Sands, Bruce E; D'Haens, Geert; Clemow, David B; Irving, Peter M; Johns, Jordan T; Gibble, Theresa Hunter; Abreu, Maria T; Lee, Scott D; Hisamatsu, Tadakazu; Kobayashi, Taku; Dubinsky, Marla C; Vermeire, Severine; Siegel, Corey A; Peyrin-Biroulet, Laurent; Moses, Richard E; Milata, Joe; Panaccione, Remo; Dignass, Axel

Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference

溃疡性结肠炎粪便微生物移植试验指南:第二次罗马共识会议

Lopetuso, Loris R; Deleu, Sara; Puca, Pierluigi; Abreu, Maria Teresa; Armuzzi, Alessandro; Barbara, Giovanni; Caprioli, Flavio; Chieng, Siew; Costello, Samuel Paul; Damiani, Andrea; Danese, Silvio; Del Chierico, Federica; D'Haens, Geert; Dotan, Iris; Facciotti, Federica; Falony, Gwen; Fantini, Massimo Claudio; Fiorino, Gionata; Gionchetti, Paolo; Godny, Lihi; Hart, Ailsa; Kupčinskas, Juozas; Iqbal, Tariq; Laterza, Lucrezia; Lombardini, Letizia; Maharshak, Nitsan; Marasco, Giovanni; Masucci, Luca; Papa, Alfredo; Paramsothy, Sudarshan; Petito, Valentina; Piovani, Daniele; Pugliese, Daniela; Putignani, Lorenza; Raes, Jeroen; Ribaldone, Davide Giuseppe; Sanguinetti, Maurizio; Savarino, Edoardo Vincenzo; Sokol, Harry; Vetrano, Stefania; Ianiro, Gianluca; Cammarota, Giovanni; Cominelli, Fabio; Pizarro, Theresa T; Tilg, Herbert; Gasbarrini, Antonio; Vermeire, Severine; Scaldaferri, Franco